# CLEER-001 PDUFA date and FDA approval status

Canonical: https://sec-api.dev/pdufa/cleer-001

> The FDA approved CLEER-001, sponsored by Rocket One Inc. (RKTO), on December 28, 2022.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: exact day.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Verified answer

### Is CLEER-001 FDA approved?

Yes. The FDA approved CLEER-001, sponsored by Rocket One Inc. (RKTO), on December 28, 2022. SEC Form 10-K: "We received FDA approval to proceed with our clinical study on December 28, 2022." [Calendar and source filings](https://sec-api.dev/pdufa/cleer-001)

Source: SEC Form 10-K, accession 0001013762-25-004108, https://www.sec.gov/Archives/edgar/data/1711786/000101376225004108/ea0233805-10k_hoth.htm (retrieved 2026-11-12). Last confirmed 2025-03-28. Cite: https://sec-api.dev/pdufa/cleer-001#answer

## Key facts

| Field | Value |
| --- | --- |
| Drug | CLEER-001 |
| Codes | CLEER-001 |
| Sponsor | Rocket One Inc. (RKTO) https://sec-api.dev/companies/rkto/catalysts |
| Indications | high unmet medical needs, today |
| Modality |  |
| FDA designations | none disclosed |

## Timeline

### December 28, 2022: FDA approval

- Status: completed, approved. Date confidence: exact.
- First seen 2025-03-28, last confirmed 2025-03-28.
- SEC Form 10-K (accession 0001013762-25-004108): "We received FDA approval to proceed with our clinical study on December 28, 2022." https://www.sec.gov/Archives/edgar/data/1711786/000101376225004108/ea0233805-10k_hoth.htm

### April 15, 2025: interim data readout

- Status: completed, positive. Date confidence: exact. Stage: 2. Indication: high unmet medical needs, today.
- First seen 2025-04-15, last confirmed 2025-04-15.
- Press release filed with the SEC (EX-99) (accession 0001213900-25-031763): "York, NY — April 15, 2025 — Hoth Therapeutics, Inc.(NASDAQ: HOTH), a biopharmaceutical company focused on developing innovative therapies for patients with high unmet medical needs, today announced positive interim data from the open-label portion of its Phase 2a clinical trial, CLEER-001, evaluating HT-001 for the treatment of pruritus associated with skin toxicities caused by Epidermal Growth Factor Receptor (EGFR) inhibitors." https://www.sec.gov/Archives/edgar/data/1711786/000121390025031763/ea0238201ex99-1_hoth.htm

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/pdufa/cleer-001.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "CLEER-001 PDUFA date and FDA approval status." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/pdufa/cleer-001

```bibtex
@misc{secapidev_pdufa_cleer_001_20261116,
  title        = {CLEER-001 PDUFA date and FDA approval status},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/pdufa/cleer-001}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_pdufa_cleer_001_20261116","title":"CLEER-001 PDUFA date and FDA approval status","publisher":"sec-api.dev","URL":"https://sec-api.dev/pdufa/cleer-001","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
